# FDA Inspection 1140527 - allphamed PHARBIL Arzneimittel GmbH - October 01, 2020

Source: https://www.keypedia.com/records/fda_inspections/allphamed-pharbil-arzneimittel-gmbh/3d06affc-8c69-4deb-b5ac-5d1bca3bd78a
Source feed: FDA_Inspections

> FDA Inspection 1140527 for allphamed PHARBIL Arzneimittel GmbH on October 01, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1140527
- Company Name: allphamed PHARBIL Arzneimittel GmbH
- Inspection Date: 2020-10-01
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1305638 - 2024-11-19](https://www.keypedia.com/records/fda_inspections/allphamed-pharbil-arzneimittel-gmbh/40718a0d-adce-49e3-873c-00827b957778)
- [FDA Inspection 1305638 - 2024-11-19](https://www.keypedia.com/records/fda_inspections/allphamed-pharbil-arzneimittel-gmbh/6cd9bd11-00eb-4ccd-9bff-c1928bf67c4a)
- [FDA Inspection 1030230 - 2017-09-29](https://www.keypedia.com/records/fda_inspections/allphamed-pharbil-arzneimittel-gmbh/e3244707-32c9-44a4-be55-11cccbdd2edf)
- [FDA Inspection 935795 - 2015-07-10](https://www.keypedia.com/records/fda_inspections/allphamed-pharbil-arzneimittel-gmbh/afb09deb-04a9-492a-87a9-bc0421fe1716)
- [FDA Inspection 894011 - 2014-09-05](https://www.keypedia.com/records/fda_inspections/allphamed-pharbil-arzneimittel-gmbh/6e46d815-e745-4715-bae1-f71d9eb5b568)

Company: https://www.keypedia.com/companies/allphamed-pharbil-arzneimittel-gmbh/5f5dbcea-8898-466c-a71e-ac9037437465

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c